ArticleBioengineered2021

Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.

Fangling Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.